UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 去勢抵抗性前立腺癌（CRPC）の治療法の概要overview of the treatment of castration resistant prostate cancer crpc [show details]
…test prostate tumor tissue for assessment of somatic genomic alterations. This may reveal potentially targetable abnormalities for which approved drugs are available regardless of tumor type (eg, a PARP …
2. 癌免疫療法の原則principles of cancer immunotherapy [show details]
…increasing understanding of the importance of immune recognition of multiple patient-specific, tumor-specific antigens, efforts to develop therapeutic vaccines against cancer are beginning to explore the use …
3. 原発不明の腺癌adenocarcinoma of unknown primary site [show details]
…and rule out other tumor types such as hematologic malignancies, sarcomas, neuroendocrine carcinomas, or germ cell tumors. In most instances, IHC is successful in defining the tumor lineage of poorly …
4. 陰茎癌：疫学、危険因子、病理carcinoma of the penis epidemiology risk factors and pathology [show details]
… targeted utilizing antigen specific T cell therapy to induce tumor regression in other HPV associated squamous malignancies . These components may play a role in treatment response and overall survival. …
5. 新たに診断された前立腺癌の初回の病期分類および評価initial staging and evaluation of men with newly diagnosed prostate cancer [show details]
…management. Additional features of the tumor that may have prognostic significance are the number and percentage of positive core biopsies, the presence of tumor perineural invasion, the presence of lymphovascular …

Related Pictures

新たながん免疫療法における Science - ppt download ミニ移植長崎大学輸血部長井一浩. - ppt download RayBio® 腫瘍関連自己抗体プロテインアレイ | 腫瘍関連抗原特異樹状細胞による抗原提示 | 薬学部田中研究室 Rolf Stahel教授からの書簡会員各位今回、このETOPスライドセット認定看護師研修センターホスピスケア分野がんのプロセスと